Pfizer Heads for Fight on Tax-Saving Allergan Deal

Drug maker’s proposed merger with Dublin-based Allergan comes as U.S. releases new rules to curb so-called inversion deals.

from WSJ.com: US Business http://ift.tt/1X1OJze
via IFTTT